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Abstract A 25 amino acid segment (Glu666^Pro691) of the II-III
loop of the K1 subunit of the skeletal dihydropyridine receptor,
but not the corresponding cardiac segment (Asp788^Pro814),
activates skeletal ryanodine receptors. To identify the structural
domains responsible for activation of skeletal ryanodine recep-
tors, we systematically replaced amino acids of the cardiac II-III
loop with their skeletal counterparts. A cluster of five basic
residues of the skeletal II-III loop (681RKRRK685) was
indispensable for activation of skeletal ryanodine receptors. In
the cardiac segment, a negatively charged residue (Glu804)
appears to diminish the electrostatic potential created by this
basic cluster. In addition, Glu800 in the group of negatively
charged residues 798EEEEE802 of the cardiac II-III loop may
serve to prevent the binding of the activation domain.
z 1999 Federation of European Biochemical Societies.
Key words: Dihydropyridine receptor; Ryanodine receptor;
Excitation-contraction coupling; Sarcoplasmic reticulum;
Synthetic peptide
1. Introduction
Excitation-contraction coupling (E-C coupling), the series
of events in cardiac and skeletal muscle by which depolariza-
tion of the external membrane evokes a mechanical contrac-
tion, is largely dependent on molecular interactions between
the dihydropyridine receptor (DHPR) of the external mem-
brane and the Ca2 release channel/ryanodine receptor (RyR)
of the sarcoplasmic reticulum (SR). In the heart, a small in£ux
of Ca2 through DHPRs triggers the opening of RyRs [1,2].
In skeletal muscle, external Ca2 is not required for Ca2
release [3]. Instead, a direct physical interaction between the
DHPR and the RyR is thought to mediate E-C coupling [4,5].
DHPR and RyR subtypes dictate the di¡erent E-C coupling
modalities. In skeletal muscle paralyzed by the absence of the
K1 subunit of the DHPR, expression of the cardiac K1 subunit
results in Ca2-dependent (‘cardiac-type’) E-C coupling. Con-
versely, expression of a chimeric K1 subunit that is entirely
cardiac except for the cytoplasmic loop between repeats II
and III (the II-III loop) restores voltage-dependent (‘skele-
tal-type’) E-C coupling [6]. In transgenic mice that lack skel-
etal RyR (RyR1), transfection of myoblasts with RyR1 re-
stores the voltage-dependent Ca2 release, however,
transfection with cardiac RyR (RyR2) requires external
Ca2 for SR Ca2 release [7]. Thus, speci¢c protein-protein
interactions between the skeletal DHPR and RyR1 are re-
sponsible for coupling membrane depolarization to Ca2 re-
lease. The skeletal II-III loop plays a prominent role in these
interactions. Indeed, the skeletal II-III loop activates puri¢ed
RyR1 [8] and a 20 amino acid segment of the skeletal II-III
loop (Thr671^Leu690), but not the corresponding cardiac seg-
ment, induces Ca2 release from SR vesicles [9]. In the present
report, we compared an active segment of the skeletal II-III
loop with its inactive cardiac counterpart to de¢ne the struc-
tural elements that support, and those that prevent, the acti-
vation of RyR1.
2. Materials and methods
2.1. Preparation of SR microsomes
Skeletal and cardiac SR-enriched microsomes were isolated from
rabbit white back and leg muscle and pig hearts, respectively, as
previously described [10]. Microsomes from the last centrifugation
were suspended in 0.3 M sucrose, 0.1 M KCl and 5 mM Na-PIPES
(pH 7.2)
2.2. Synthesis and modelling of peptides
Peptides were synthesized by the solid phase methodology with
Fmoc (N-(9-£uorenyl)methoxycarbonyl) amino acids in an Applied
Byosystems peptide synthesizer (Model 432A), as described [11]. Pep-
tides were cleaved and deprotected with 95% tri£uoroacetic acid and
puri¢ed in a reverse-phase C18 HPLC column, also as described in
[11]. The structure and purity of the peptides were con¢rmed by mass
spectrometry. Peptides were quanti¢ed in a Model 8452A Hewlett-
Packard Spectrophotometer using the expression 1 A214 nm = 20 mg
peptide/ml. Structural models were obtained using Insight II Discover
software from Biosym Technologies (San Diego, CA, USA), running
on a Silicon Graphics Octane RS10000 Workstation. Models were
built by the Biopolymer module of Insight II on the basis of the
amino acid sequence propensity to form K-helix, random coil and
L-sheet structures, as determined by the programs Agadir [12] and
Gor IV [13] in the Expert Protein Analysis System (ExPASy) website
(http://www.expasy.ch/www/tools.html). The structures were energy
minimized using the Discover force ¢eld. 500 steps of minimization
were performed using the steepest descent algorithm method until a
root mean square deviation of 0.001 was obtained.
2.3. [3H]ryanodine binding assay
[3H]ryanodine (7 nM) was incubated for 90 min at 36‡C with 40^50
Wg of rabbit skeletal or pig cardiac SR vesicles in 0.1 ml of medium
containing 0.2 M KCl, 10 WM CaCl2 and 10 mM Na-HEPES (pH 7.2)
in the absence and presence of peptides. Free and bound ligands were
separated by rapid ¢ltration through Whatman GF/B glass ¢ber ¢l-
ters, as described [11,14].
2.4. Planar bilayer technique
Rabbit skeletal RyRs were reconstituted into Muller-Rudin planar
lipid bilayers as described previously [14,15]. Single channel data were
collected at steady voltages (+35 mV) for 2 min in symmetrical 300
mM cesium methanesulfonate and 10 mM Na-HEPES (pH 7.2). Con-
taminant Ca2 ions (V5^7 WM free Ca2 as assessed by a calibration
curve) served to activate RyRs. Signals were digitized at 4 kHz and
analyzed after ¢ltering with a low-pass 8-pole Bessel ¢lter at a sam-
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pling frequency of 1.5 kHz. Date acquisition and analysis were done
with Axon instruments software and hardware (pClamp V6.03, Digi-
data 200 AD/DA interface).
2.5. Spectrophotometric Ca2+ release assay
Skeletal SR vesicles (V50 Wg of protein) were mixed in a 1 ml
solution containing 95 mM KCl, 7.5 mM Na-pyrophosphate, 250
WM antipyrylazo III, 1.5 mM MgATP, 25 Wg/mg creatine phosphoki-
nase, 5 mM phosphocreatine and 20 mM K-MOPS, (pH 7.0). The
solution was placed in a cuvette, thermostated at 37‡C and allowed to
equilibrate for 2 min. Changes in free Ca2 were monitored by
changes in the absorbance of antipyrylazo at 710 nm and subtraction
of the absorbance at 790 nm, at 1 s intervals, using a diode array
spectrophotometer (Hewlett Packard Model 8452A). Vesicles were
actively loaded with CaCl2 until levels close to the ¢lling capacity
(V2 Wmol of total Ca2/mg protein, usually four additions of 10
nmol of CaCl2). The absorbance signals were calibrated by addition
of a known amount of Ca2 to the complete transport mixture in the
presence of the Ca2 ionophore A23187 to prevent Ca2 accumula-
tion.
3. Results and discussion
3.1. The e¡ect of cardiac and skeletal II-III loop segments on
[3H]ryanodine binding
Earlier work by El-Hayek et al. [9] suggested that the ca-
pacity of the 138 amino acid II-III loop of the skeletal DHPR
to activate RyR1 could be attributed to a 20 amino acid seg-
ment encompassing the sequence Thr671^Leu690. We synthe-
sized the corresponding segment of the cardiac II-III loop to
test its capacity to activate RyRs. Fig. 1A shows that, with the
exception of a few amino acids (gray boxes), the 25 amino
acid peptide of the cardiac sequence (peptide Car) is highly
homologous to the skeletal II-III loop segment (peptide Ske)
that activates RyR1. However, while peptide Ske stimulates
[3H]ryanodine binding to skeletal SR with a half-maximal
e¡ective concentration (ED50) = 0.8 WM, peptide Car stimu-
lates binding only marginally (Fig. 1B). The stimulating e¡ect
of peptide Ske cannot be attributed to the peptide mass or net
electrical charge because a scrambled peptide Ske (a synthetic
peptide with amino an acid composition identical to peptide
Ske but in a random sequence) lacks the capacity to activate
[3H]ryanodine binding (Fig. 1B). Thus, the stimulating e¡ect
of peptide Ske seems to require a de¢ned amino acid se-
quence. Accordingly, amino acid substitutions in peptide
Car that yield a peptide more similar to peptide Ske should
gradually enhance its potential to activate RyRs.
To de¢ne the minimal structural elements that support or
prevent activation of RyR1 by peptide segments of the II-III
loop, we synthesized truncated forms of peptide Car and full-
length versions of the same with amino acid substitutions in
one or more positions to resemble peptide Ske (Fig. 1A). Two
regions of electrically charged amino acids in peptide Car are
notoriously divergent from those in peptide Ske and were
therefore targeted for mutations. Region 1 (Fig. 1A) is of
high electrostatic potential in peptide Car as it is formed of
¢ve consecutive glutamate residues (798EEEEE802). Con-
versely, region 2 is a cluster of ¢ve basic residues in peptide
Ske (681RKRRK685), a cluster that is interrupted by the neg-
atively charged residue glutamate in peptide Car
(803KERKK807). This cluster of ¢ve basic amino acids in pep-
tide Ske is believed to be important for activation of RyR1
[16]. For instance, replacing Arg684 with glutamate renders
peptide Ske inactive [16]. The participation of other regions
of peptide Ske in the activation of RyRs remains uncertain.
We therefore designed several peptides to investigate the role
of these structural domains separately. Peptides M1 and M2
were designed to test the hypothesis that the disruption of the
cluster of basic amino acids in region 2 was the only structural
basis for the lack of e¡ect of peptide Car. The other peptides
were designed to investigate the role of region 1 and the con-
served ¢rst 12 amino acids. Peptides CT and M3 are truncated
forms of peptide Car that lack region 1 and the ¢rst 12 amino
acids. Peptides M4, M5 and M6 are full-length versions of
peptide Car with a skeletal-like region 2 and mutations in
region 1.
We ¢rst investigated the role of the cluster of ¢ve basic
amino acids. Fig. 2A shows that the truncated peptide M3,
but not peptides M1, M2 and CT, was capable of stimulating
[3H]ryanodine binding to skeletal SR in a substantial manner.
Peptide M3 had an ED50 = 10 WM and increased binding to
the same extent as peptide Ske (212 þ 18% and 210 þ 10%,
respectively, n = 4). The other mutated peptides were without
an e¡ect at concentrations up to 100 WM. The lack of e¡ect by
peptide CT was not surprising given that its cluster of basic
residues is, like in peptide Car, disrupted by glutamate. How-
ever, peptides M1 and M2 do not contain the negatively
charged residue and in fact, M2 displays the continuous clus-
ter of ¢ve basic residues. Since the active peptide M3 is iden-
tical to the last twelve amino acids of the inactive peptide M2,
a plausible interpretation of these results is that the ¢rst half
of peptide M2, particularly its region 1, prevented the activa-
Fig. 1. Synthetic peptides used in this study and the e¡ect on
[3H]ryanodine binding. (A) Amino acid sequences (in one letter
code) of synthetic peptides corresponding to skeletal (Ske) and car-
diac (Car) segments of the II-III loop and di¡erent mutants (M1^
M6). The amino acid sequences (but not the synthetic peptides)
have been arbitrarily broken in four groups to facilitate analysis.
Shaded areas indicate a lack of homology between peptides Ske and
Car. Bold letters in peptides M1^M6 indicate the mutated residues.
(B) The e¡ect of peptides Ske, Car and a scrambled peptide Ske
(RLKSQKMRATGKAERARSEK) on [3H]ryanodine binding to
skeletal SR. The binding assay was carried out as described in Sec-
tion 2. Speci¢c binding in the absence of peptides (control, 100%)
was 0.33 þ 0.08 pmol/mg protein.
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tion of RyR1. We thus tested the role of region 1 in the next
experimental series.
We synthesized peptides M4, M5 and M6, which carry one
or more mutations in region 1 (Fig. 1A). Since the above
results suggested that the cluster of ¢ve basic residues was
essential for activation, all three peptides were designed to
contain that structural motif. Fig. 2B shows that peptide
M6, but not peptides M4 and M5, stimulated [3H]ryanodine
binding signi¢cantly. Although peptides M4 and M5 carry
one and two substitutions, respectively, that eliminate an
equal number of negative electrical charges in region 2, they
were unable to increase [3H]ryanodine binding. Only peptide
M6, whose regions 1 and 2 are essentially identical to peptide
Ske, was capable of increasing binding, albeit to a maximum
(170 þ 10%, n = 4) and with a potency (ED50 = 10.5 WM), low-
er than the latter. Taken together, the results of Fig. 2A and B
suggest that one or more amino acids in the cluster of ¢ve
basic residues is indispensable for activation of [3H]ryanodine
binding to RyR1. In peptide Car, Glu804 appears to diminish
the electrostatic potential created by this basic cluster. In
addition, the group of negatively charged residues
(798EEEEE802) may serve as an inhibitory domain to prevent
the binding of the activation domain. However, the proposed
interaction appears to involve more than these two clusters of
charged residues because their conversion to a skeletal-like
sequence in peptide Car does not yield a peptide as e¡ective
as peptide Ske. Based on previous work, Ser687 of the skeletal
II-III loop appears to be important for activation of RyRs
[16,17]. In peptide M6, Ser687 corresponds to Ala809, a residue
similar to Ser, except for the lack of the hydroxyl group in the
L-carbon. It is therefore likely that the reduced e⁄cacy of
peptide M6 is at least partly due to the absence of the
hydroxyl group contributed by Ser687.
In RyR1 knock-out (dyspedic) mice, transfection of skeletal
myoblasts with cDNA encoding RyR1 restores the voltage-
dependent (‘skeletal-type’) Ca2 release, however, myotubes
transfected with RyR2 require external Ca2 for Ca2 release
[7]. This suggests that the structural domain of RyR1, capable
of coupling the membrane voltage to Ca2 release, is absent in
RyR2 [18]. Fig. 2C shows that, at concentrations up to 100
WM, none of the peptides, including peptide Ske, were capable
of increasing [3H]ryanodine binding to RyR2. Thus, the e¡ect
of the peptides appears to be speci¢c for RyR1. The results
are compatible with the involvement of speci¢c RyR subtypes
to elicit the two di¡erent modalities of E-C coupling.
3.2. Functional e¡ects of active peptides M3 and M6
To determine whether the increase of [3H]ryanodine binding
to skeletal SR by peptides M3 and M6 (Fig. 2A and B) had a
functional correlation, we tested their e¡ect in Ca2 release
experiments and on single RyR reconstituted in lipid bilayers.
Fig. 3 shows that peptides M3 (B) and M6 (D) elicited Ca2
release from actively loaded skeletal SR vesicles in a dose-
dependent manner. Addition of 1 WM peptide M3 or M6 to
the incubation reaction released v65% and 50%, respectively,
of the Ca2 trapped in the SR vesicles. The e¡ect of the
peptides was blocked by ruthenium red (not shown), consis-
tent with Ca2 release occurring by RyRs. Fig. 3 also shows
that 0.1 and 0.5 WM of peptide M3 (A) or the same concen-
trations of peptide M6 (C) added to the cis (cytoplasmic) side
of RyR1 induced the appearance of subconductance states.
The latter had at least two current amplitude values. In one
case, openings were temporarily stable in a subconductance
state corresponding to V3/4 of the full conductance level
(¢rst trace after addition of peptide M3). In the second and
most frequent case, the subconductance state corresponded to
V1/4 of the full conductance level. In both cases, current
transitions from modi¢ed to normal amplitude levels were
frequent. Although of a small amplitude, both types of
subconductance states displayed a mean open time that was
s 50-fold longer than that of unmodi¢ed channels. The ion
£ow would therefore be expected to be greater for a peptide
M3- or peptide M6-modi¢ed channel despite its lower con-
ductance. This e¡ect may explain the Ca2 releasing proper-
ties of the peptides. Hence, the capacity of peptides M3 and
M6 to increase [3H]ryanodine binding appears to be the result
of an increase in the overall activity of the channel. In support
of this notion, peptide Ske evoked similar functional e¡ects on
RyR1 [16], but the inactive peptides Car and M2 did not (not
shown).
3.3. Structural models of the skeletal and cardiac II-III loop
peptides
To visualize more integrally the spatial arrangement of the
putative binding domains, we created a three-dimensional
model of peptides Ske and Car based on the propensity of
their amino acid sequence to form K-helix, random coil and L-
sheet strands. The model (Fig. 4) recapitulates the main ¢nd-
Fig. 2. Activation of [3H]ryanodine binding by selected peptides.
Binding of 7 nM [3H]ryanodine to skeletal SR (A and B) and to
cardiac SR (C) was conducted in the absence (control, 100%) or the
presence of indicated concentrations of synthetic peptides, as de-
scribed in Section 2. Speci¢c binding to skeletal and cardiac SR was
0.55 and 0.17 pmol/mg protein, respectively. Data points represent
the mean þ S.D. of n = 4 independent experiments.
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ings of this study and provides a structural framework to
rationalize the activity (or lack thereof) of native and mutant
peptides. To construct the model, we used two di¡erent algo-
rithms (Agadir [12] and Gor IV [13], see Section 2) that pre-
dict helix/coil/L-sheet transitions and short range interactions
in monomeric peptides under de¢ned conditions of pH, tem-
perature and ionic strength. In small and highly hydrophilic
peptides such as peptides Ske and Car, this is relatively
straightforward and, indeed, both algorithms yielded essen-
tially identical results. The amino-termini of peptides Ske
and Car (666EAESL- and 788DAESL-, respectively), as well
as their carboxyl-termini (-SRGLP691 and -RTASP814, respec-
tively), lack propensity to form ordered secondary structures
and are therefore assigned as random coil. In the carbon
backbone representation (Fig. 4, left), they appear as thin
threads extending outward from the well-ordered central
core of the peptides. Although the model provided in Fig. 4
represents the structural conformation most thermodynami-
cally favored, the amino- and carboxyl-termini of both pep-
tides underwent major spatial transitions during energy min-
imization, suggesting that these segments may adopt several
arrangements in relation to the central core. The central ami-
no acids 671TSAQKA676 and 793TSAQKE798 of peptides Ske
and Car, respectively, have a high probability (v 90%) of
forming K-helix and so do the neighboring sequences
679EERKRRKM686 and 801EEKERKKLA809 of peptide Ske
and Car, respectively. These two sets of K-helices appear as
thick ribbons in the backbone representation of the peptides,
joined by thin threads representing two randomly coiled res-
idues (677KA678 and 799EE800, respectively).
The space¢ll model (Fig. 4, middle) indicates the spatial
orientation of all atoms of the amino acid residues forming
the carbon backbone. A conspicuous di¡erence between pep-
tides Ske and Car is that in the former peptide, there is a
cluster of positively charged residues aligned towards the
same side of the molecule. These residues are outlined in color
in Fig. 4, right, and correspond to Lys677, Arg681, Lys682,
Arg684 and Lys685. Not surprisingly, most of these positively
charged residues are found in region 2, except for Lys677,
which is the second residue of region 1. That Lys677 contrib-
utes to the cluster of basic residues is counter-intuitive-based
on the linear sequence, but is possible because in an K-helix,
amino acids spaced three and four apart in the linear sequence
are spatially close to one another. Each residue is related to
the next one by a 100‡ rotation (or 3.6 residues per turn of K-
helix) and residues two apart in the linear sequence are on
opposite sides of the helix. This explains why not all basic
residues of region 2 contribute to the formation of this struc-
tural domain. In sharp contrast, the corresponding region of
peptide Car is composed of basic (Arg805 and Lys807), hydro-
phobic (Leu808) and negatively charged (Glu800 and Glu804)
residues (Fig. 4, right). Since mutations in this structural do-
main determine the activity of peptides Ske and Car, we pos-
tulate that residues within it are part of the active binding site.
Superposing these structural domains reveals that Lys682 and
Arg684 of peptide Ske correspond to Arg805 and Lys807 of
peptide Car. Because both pairs of residues are of the same
electrical charge, they probably would favor the binding of
peptide Car to RyRs. However, Glu800 and Glu804 of peptide
Car contribute electrical charges of an opposite sign from
residues that in peptide Ske appear favorable for activation
of RyRs (Lys677 and Arg681). Supporting the adverse role of
Fig. 3. The functional e¡ect of peptides M3 and M6 on RyR1. Rabbit RyR1 channels were reconstituted in planar lipid bilayers [14,16] and
activated by 10 WM (cis) cytosolic Ca2 in the absence (‘control’) and V1 min after addition of indicated concentrations of peptide M3 (A) or
peptide M6 (C) to the cis side. The peptides induced the appearance of subconductance states of a long lifetime (arrows). Holding potential:
335 mV for all traces. c = closed, o = open. Ca2 release from actively loaded SR vesicles by peptide M3 (B) or peptide M6 (D) was measured
with the spectrophotometric Ca2 indicator Antipyrylazo III, as described [16]. Arrows indicate the addition of 10 nmol of Ca2 to the 1 ml re-
action medium. Thapsigargin (1 WM) was added simultaneously with the peptides to block Ca2 uptake by the SR. When an equilibrium was
reached, the Ca2 ionophore A23187 (5 WM) was added to assess the SR Ca2 content (asterisks). Calibration bars: 60 s (horizontal) and 5 WM
Ca2 (vertical).
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these negatively charged residues is the fact that peptides M1,
M2, CT, M4 and M5, which contain Glu800 or Glu804 (Fig.
1A), were incapable of activating [3H]ryanodine binding (Fig.
2). The most dramatic example was peptide M5, which was
turned into an active peptide (peptide M6) only after removal
of Glu800. The model may also explain why the truncated
peptide M3, while endowed with a minimal activatory se-
quence (the cluster of basic residues of region 2 [19]), was
less e¡ective than the whole peptide Ske to activate RyRs
despite the absence of Glu800 and Glu804. A plausible explan-
ation is that peptide M3 lacks the positive electrical charge
corresponding to Lys677 of peptide Ske. The role of Leu808 of
peptide Car (which appears in place of Lys685 of peptide Ske)
is uncertain because we did not mutate this residue.
In summary, our results with synthetic peptides correspond-
ing to de¢ned segments of the II-III loop identify speci¢c
amino acids indispensable for activation of RyRs and those
unfavorable for the binding of the active domain. In peptide
Ske, Arg681, Lys682, Arg684 and Lys685 within the cluster of
basic residues of region 2 appear as essential components of
the active domain, with Lys677 of region 1 playing a comple-
mentary role. The high electrostatic potential created by this
conglomerate of positive electrical charges is absent in peptide
Car which, in fact, displays some features that are counter-
productive for activation of RyRs, such as the presence of
Glu800 and Glu804. Although the participation in E-C coupling
of the segment of the II-III loop studied here has been chal-
lenged [20] and awaits further testing, our results provide a
structural framework for a mechanical model in which speci¢c
amino acids of the II-III loop are capable of interacting with
RyRs and triggering Ca2 release.
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